MARKET

PHVS

PHVS

Pharvaris N.V.
NASDAQ
16.94
+0.03
+0.15%
Opening 12:52 03/14 EDT
OPEN
16.79
PREV CLOSE
16.91
HIGH
17.12
LOW
16.62
VOLUME
10.62K
TURNOVER
--
52 WEEK HIGH
26.99
52 WEEK LOW
14.14
MARKET CAP
918.44M
P/E (TTM)
-5.8818
1D
5D
1M
3M
1Y
5Y
1D
Pharvaris (PHVS) Gets a Buy from Morgan Stanley
TipRanks · 4d ago
Weekly Report: what happened at PHVS last week (0303-0307)?
Weekly Report · 4d ago
Pharvaris Price Target Maintained With a $55.00/Share by Citizens Capital Markets
Dow Jones · 03/03 15:20
Citizens Capital Markets Reiterates Market Outperform on Pharvaris, Maintains $55 Price Target
Benzinga · 03/03 15:10
Morgan Stanley Remains a Buy on Pharvaris (PHVS)
TipRanks · 03/03 13:07
Pharvaris reports safety and efficacy data of deucrictibant
TipRanks · 03/03 11:55
Pharvaris Showcases Phase 3 Data on Deucrictibant for Hereditary Angioedema at AAAAI-WAO Congress
Benzinga · 03/03 11:52
Weekly Report: what happened at PHVS last week (0224-0228)?
Weekly Report · 03/03 09:22
More
About PHVS
More
Pharvaris NV is a Netherlands-based company primarily engaged in the biopharmaceutical industry. The Company focuses on developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. Their key product is Deucrictibant (PHA121, PHA-022121), which is a small-molecule bradykinin B2 receptor antagonist. It is intended for both the on-demand and prophylactic treatment of HAE attacks. Deucrictibant has been studied in vitro, ex vivo, and in vivo models to assess its effectiveness in blocking the bradykinin B2 receptor. The Company is developing deucrictibant for on-demand use as PHVS416, a softgel capsule, and for prophylactic use as PHVS719, an extended-release tablet.
Recently
Symbol
Price
%Change

Webull offers Pharvaris NV stock information, including NASDAQ: PHVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHVS stock methods without spending real money on the virtual paper trading platform.